Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery ...

Proxima, a biotech startup using artificial intelligence to design drugs that control protein interactions, raised $80 ...

Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...

Opportunities in RNA Targeting Small Molecule Drug Discovery are driven by advances in RNA biology, structural analysis, and ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.

Researchers in China have unveiled a new AI framework that could accelerate the discovery of new medicines. DrugCLIP can scan ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding ...

Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...

Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on ...